Archives

by in
Entry Author Date Location
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
LinkedIn: The Quiet Force Transforming Biotech & Pharma 11/05/12 National
The New Power Players in Drug R&D Are Wearing Bright T-Shirts 10/29/12 National
Who Will Survive the Biotech VC Downturn? The Young and the Proven 10/22/12 National
Which VCs Are Poised to Cash In On the Biotech IPOs of 2012? 10/15/12 National
Watch Out SF, Boston Is Turning Into Biotech’s No. 1 Cluster 10/08/12 National
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Who Should Life Science Pros Follow on Twitter? 09/24/12 National
Biotech Begins to Come of Age on Twitter 09/17/12 National
The FDA Turns Friendly Toward Pharma in 2012 09/10/12 National
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Alzheimer’s R&D Isn’t Doomed, it’s Learning From Failure 08/20/12 National
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names 08/13/12 National
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts 08/06/12 National
A Lonely Voice Asking Tough Questions on Cancer Cost-Effectiveness 07/30/12 National
Scarcity of Samples Threatens Personalized Medicine 07/23/12 National
A Summer Reading List for Biotech Pros 07/16/12 National
The Best Boring Companies in Biotech 07/09/12 National
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
Three Good Things About BIO 2012, and Four Not-so-Good 06/18/12 National
SD Biotech Roundup: Life Technologies, KFx Medical, Shire, & More 06/15/12 San Diego
Ready or Not, Genomics is Coming to a Hospital Near You 06/11/12 National
Why Would a Biotech Company Go the Trouble of Changing Its Name? 06/04/12 National
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
Antibiotic R&D is in Trouble: Here’s One Way to Fix It 05/07/12 National
SD Life Sciences Roundup: Gen-Probe, Zogenix, & the Innovation Economy 05/03/12 San Diego
Biotech IPOs Start to Show Some Modest Signs of Life 04/30/12 National
What Are the Hottest Targets in Biotech Today? 04/23/12 National
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Page 2 of 5 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.